MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY:XLV)

143.26 -2.48 (-1.70%)
Official Closing Price Updated: 8:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
42 43 Next >
News headline image
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags ↗
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners. 
Via Talk Markets
News headline image
Financials And Tech Continue To Split: Your Sector Trade Ideas For The Week Ahead ↗
Current trade opportunities for Financials and Tech along with other sectors setting up trade logic. 
Via Talk Markets
News headline image
Energy & Financials Lead, But The Flight To Quality Has Begun ↗
It's easy to get suckered into thinking the crisis is over and buy the most oversold stocks. For financials, this comes with significant risk as the 
Via Talk Markets
News headline image
Can Healthcare Stocks Survive Macro Headwinds? ↗
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
News headline image
Budding Sign Not To Miss ↗
Encouraging signs from corporate junk bonds, stocks are likely to get a tailwind to open 2023. 
Via Talk Markets
News headline image
Sector Performance Experiences A Historical Divergence ↗
The first quarter of 2023 is coming to a close next week, and checking in on year-to-date performance, there has been a big divergence between the winners and losers. 
Via Talk Markets
News headline image
Small Cap Biotechs Slammed By SVB Collapse ↗
Nothing like a banking crisis to start off a weekend. But maybe by the end of this upcoming week of turmoil we'll worry less about inflation. 
Via Talk Markets
News headline image
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities ↗
 
Via Benzinga
News headline image
U.S. Weekly Fund-Flows Insight Report: Investors Embrace Both Fixed Income And Equity ETFs ↗
As investors appeared to ignore rising Treasury yields, stocks generally managed to remain on the plus-side for the fund-flows week. 
Via Talk Markets
News headline image
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births ↗
 
Via Benzinga
News headline image
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗
 
Via Benzinga
News headline image
A Market And Economy Exceeding Expectations ↗
Knowing the economy and investment market are not one and the same, and can function out of sync at times, possibly the current environment is such that they are actually in sync. 
Via Talk Markets
News headline image
S&P 500 2022 Q4 Earnings Review: Swing And A Miss ↗
In many ways, this quarter behaved in a way that met the expectations of most market commentators, earnings are too high, an erosion of pricing power since the pandemic, and that higher costs will bite... 
Via Talk Markets
News headline image
Identifying The Dimension Where Deterministic Chaos Is Alive In The Stock Market ↗
We have estimated approximate entropy for the S&P 500 and its SPDR ETF and we have noticed that all of them have non-linear dependence patterns for the dimension of 3 or 4 days. 
Via Talk Markets
News headline image
Tuesday Talk: My Sweet CPI ↗
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
News headline image
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers ↗
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
News headline image
A Bull Market Is Coming. Should You Return to Growth Stocks? ↗
Growth stocks could be among the first to rally in a bull market. 
Via The Motley Fool
News headline image
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years ↗
Funneling money into this fund can drastically simplify your investing strategy. 
Via The Motley Fool
News headline image
10 Names For Half The Move ↗
In January, sectors like Tech, Communication Services, and Consumer Discretionary saw massive outperformance following the opposite playing out throughout 2022. 
Via Talk Markets
News headline image
Sector Divergence, Earnings Stats ↗
Over these last few weeks, as the broad market has rallied, we've definitely seen some sector divergence. 
Via Talk Markets
News headline image
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January ↗
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
News headline image
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
News headline image
Rotating Regimes – What To Plan For In 2023 ↗
Throughout the second half of 2022, active managers turned to sector rotation to help mitigate and recover from substantial losses incurred already. Rotation into and out of low and high volatility... 
Via Talk Markets
News headline image
Markets At Key Turning Point With Major Earnings Ahead ↗
We saw initial selling in the market today and will be watching this particular key price level very closely this week and beyond. 
Via Talk Markets
News headline image
Top Sector For 2023 ↗
Technical analysis and opinion on each sector in the stock market and which ones are likely to do the best, and which ones are most likely to lag the overall market. 
Via Talk Markets
News headline image
Best ETFs, Funds, and Stocks of 2022. A Preview to 2023. ↗
In 2022, high inflation and rising bond yields emerged as headwinds for stocks. The S&P 500 declined by over 18%, marking its worst yearly showing since 2008. 
Via Talk Markets
News headline image
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing” ↗
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
News headline image
Market Awaits The CPI And Financial Earnings - Be Ready! ↗
A look at the upcoming big events this week, which stocks are leading the rally with double-digit gains so far in 2023 and which smaller number of stocks started the year weak. 
Via Talk Markets
News headline image
Biden, Trump, DeSantis: Cramer Says Concerns Over Next President Mean We May Be In For 'Second Leg' Of 'Vicious Rotation' Out Of Healthcare ↗
The Health Care Select Sector SPDR Fund (NYSE: XLV) ended 2022 with a modest loss of 2.08%, a relative outperformance vis-a-vis the broader S&P 500 Index, 
Via Benzinga
News headline image
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year ↗
By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk. 
Via The Motley Fool
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story